nodes	percent_of_prediction	percent_of_DWPC	metapath
Trisalicylate-choline—PTGS1—kidney cancer	0.522	0.636	CbGaD
Trisalicylate-choline—PTGS2—kidney cancer	0.299	0.364	CbGaD
Trisalicylate-choline—PTGS1—Prostaglandin Synthesis and Regulation—ANXA4—kidney cancer	0.00204	0.0627	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Prostaglandin Synthesis and Regulation—ANXA4—kidney cancer	0.00162	0.0498	CbGpPWpGaD
Trisalicylate-choline—Magnesium salicylate—PTGS1—kidney cancer	0.00154	0.344	CrCbGaD
Trisalicylate-choline—Salsalate—PTGS1—kidney cancer	0.00131	0.292	CrCbGaD
Trisalicylate-choline—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—KEAP1—kidney cancer	0.00123	0.0378	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Signaling mediated by p38-alpha and p38-beta—KRT8—kidney cancer	0.00109	0.0334	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Prostaglandin Synthesis and Regulation—ANXA2—kidney cancer	0.00107	0.0329	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS1—kidney cancer	0.000901	0.0276	CbGpPWpGaD
Trisalicylate-choline—Magnesium salicylate—PTGS2—kidney cancer	0.000883	0.197	CrCbGaD
Trisalicylate-choline—PTGS2—Prostaglandin Synthesis and Regulation—ANXA2—kidney cancer	0.000853	0.0262	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcium signaling in the CD4+ TCR pathway—FOSL1—kidney cancer	0.000843	0.0259	CbGpPWpGaD
Trisalicylate-choline—Salsalate—PTGS2—kidney cancer	0.000751	0.167	CrCbGaD
Trisalicylate-choline—PTGS2—Overview of nanoparticle effects—PTGS1—kidney cancer	0.000706	0.0216	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Prostaglandin Synthesis and Regulation—ANXA1—kidney cancer	0.000605	0.0186	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Eicosanoid Synthesis—PTGS1—kidney cancer	0.000586	0.018	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOSL1—kidney cancer	0.000546	0.0167	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—ROS1—kidney cancer	0.000543	0.0166	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Signaling mediated by p38-alpha and p38-beta—MITF—kidney cancer	0.000531	0.0163	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	0.000522	0.016	CbGpPWpGaD
Trisalicylate-choline—Somnolence—Pazopanib—kidney cancer	0.00051	0.0036	CcSEcCtD
Trisalicylate-choline—PTGS1—Biological oxidations—ACY1—kidney cancer	0.000506	0.0155	CbGpPWpGaD
Trisalicylate-choline—Dyspepsia—Pazopanib—kidney cancer	0.000505	0.00356	CcSEcCtD
Trisalicylate-choline—Hepatitis—Dactinomycin—kidney cancer	0.000504	0.00356	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Sunitinib—kidney cancer	0.000504	0.00355	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Pazopanib—kidney cancer	0.000499	0.00352	CcSEcCtD
Trisalicylate-choline—Flushing—Sunitinib—kidney cancer	0.000494	0.00349	CcSEcCtD
Trisalicylate-choline—Pain—Pazopanib—kidney cancer	0.000491	0.00346	CcSEcCtD
Trisalicylate-choline—PTGS2—Prostaglandin Synthesis and Regulation—PTGS1—kidney cancer	0.00049	0.015	CbGpPWpGaD
Trisalicylate-choline—Erythema—Sorafenib—kidney cancer	0.000482	0.0034	CcSEcCtD
Trisalicylate-choline—Sweating—Vincristine—kidney cancer	0.000481	0.0034	CcSEcCtD
Trisalicylate-choline—PTGS2—Prostaglandin Synthesis and Regulation—ANXA1—kidney cancer	0.00048	0.0147	CbGpPWpGaD
Trisalicylate-choline—Erythema multiforme—Dactinomycin—kidney cancer	0.000477	0.00336	CcSEcCtD
Trisalicylate-choline—Deafness—Capecitabine—kidney cancer	0.000474	0.00335	CcSEcCtD
Trisalicylate-choline—Abdominal pain upper—Paclitaxel—kidney cancer	0.000472	0.00333	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Sorafenib—kidney cancer	0.000472	0.00333	CcSEcCtD
Trisalicylate-choline—Flushing—Dactinomycin—kidney cancer	0.000468	0.0033	CcSEcCtD
Trisalicylate-choline—Stinging—Doxorubicin—kidney cancer	0.000465	0.00328	CcSEcCtD
Trisalicylate-choline—Erythema—Sunitinib—kidney cancer	0.000464	0.00327	CcSEcCtD
Trisalicylate-choline—PTGS2—Signaling mediated by p38-alpha and p38-beta—HSPB1—kidney cancer	0.000457	0.014	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Signaling mediated by p38-alpha and p38-beta—EIF4EBP1—kidney cancer	0.000457	0.014	CbGpPWpGaD
Trisalicylate-choline—Sweating—Gemcitabine—kidney cancer	0.000456	0.00322	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Sunitinib—kidney cancer	0.000454	0.0032	CcSEcCtD
Trisalicylate-choline—Oedema—Everolimus—kidney cancer	0.000453	0.0032	CcSEcCtD
Trisalicylate-choline—Hallucination—Vincristine—kidney cancer	0.000448	0.00316	CcSEcCtD
Trisalicylate-choline—Shock—Everolimus—kidney cancer	0.000446	0.00315	CcSEcCtD
Trisalicylate-choline—PTGS2—Calcium signaling in the CD4+ TCR pathway—JUNB—kidney cancer	0.000443	0.0136	CbGpPWpGaD
Trisalicylate-choline—Erythema—Dactinomycin—kidney cancer	0.000439	0.0031	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Everolimus—kidney cancer	0.000438	0.00309	CcSEcCtD
Trisalicylate-choline—Oedema—Erlotinib—kidney cancer	0.000437	0.00308	CcSEcCtD
Trisalicylate-choline—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—kidney cancer	0.000435	0.0133	CbGpPWpGaD
Trisalicylate-choline—Anorexia—Vinblastine—kidney cancer	0.000433	0.00306	CcSEcCtD
Trisalicylate-choline—Lethargy—Capecitabine—kidney cancer	0.000433	0.00306	CcSEcCtD
Trisalicylate-choline—Anorexia—Everolimus—kidney cancer	0.000432	0.00305	CcSEcCtD
Trisalicylate-choline—Pruritus—Temsirolimus—kidney cancer	0.000431	0.00304	CcSEcCtD
Trisalicylate-choline—Shock—Erlotinib—kidney cancer	0.00043	0.00303	CcSEcCtD
Trisalicylate-choline—Hypotension—Everolimus—kidney cancer	0.000423	0.00299	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Temsirolimus—kidney cancer	0.000417	0.00294	CcSEcCtD
Trisalicylate-choline—Anorexia—Erlotinib—kidney cancer	0.000417	0.00294	CcSEcCtD
Trisalicylate-choline—Hypocalcaemia—Doxorubicin—kidney cancer	0.000412	0.00291	CcSEcCtD
Trisalicylate-choline—Weight increased—Paclitaxel—kidney cancer	0.000407	0.00287	CcSEcCtD
Trisalicylate-choline—Pruritus—Pazopanib—kidney cancer	0.000406	0.00286	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Gemcitabine—kidney cancer	0.000404	0.00285	CcSEcCtD
Trisalicylate-choline—Somnolence—Everolimus—kidney cancer	0.000403	0.00284	CcSEcCtD
Trisalicylate-choline—Dizziness—Temsirolimus—kidney cancer	0.000403	0.00284	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Everolimus—kidney cancer	0.000399	0.00281	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Vinblastine—kidney cancer	0.000395	0.00279	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Everolimus—kidney cancer	0.000394	0.00278	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Pazopanib—kidney cancer	0.000393	0.00277	CcSEcCtD
Trisalicylate-choline—Constipation—Vinblastine—kidney cancer	0.000389	0.00274	CcSEcCtD
Trisalicylate-choline—Pain—Vinblastine—kidney cancer	0.000389	0.00274	CcSEcCtD
Trisalicylate-choline—Abdominal pain upper—Capecitabine—kidney cancer	0.000388	0.00274	CcSEcCtD
Trisalicylate-choline—Constipation—Everolimus—kidney cancer	0.000387	0.00273	CcSEcCtD
Trisalicylate-choline—Pain—Everolimus—kidney cancer	0.000387	0.00273	CcSEcCtD
Trisalicylate-choline—Vomiting—Temsirolimus—kidney cancer	0.000387	0.00273	CcSEcCtD
Trisalicylate-choline—Shock—Sorafenib—kidney cancer	0.000387	0.00273	CcSEcCtD
Trisalicylate-choline—PTGS2—S1P1 pathway—KDR—kidney cancer	0.000387	0.0119	CbGpPWpGaD
Trisalicylate-choline—Dyspepsia—Erlotinib—kidney cancer	0.000385	0.00272	CcSEcCtD
Trisalicylate-choline—Rash—Temsirolimus—kidney cancer	0.000384	0.00271	CcSEcCtD
Trisalicylate-choline—Dermatitis—Temsirolimus—kidney cancer	0.000384	0.00271	CcSEcCtD
Trisalicylate-choline—Headache—Temsirolimus—kidney cancer	0.000382	0.00269	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Erlotinib—kidney cancer	0.00038	0.00268	CcSEcCtD
Trisalicylate-choline—Dizziness—Pazopanib—kidney cancer	0.000379	0.00268	CcSEcCtD
Trisalicylate-choline—Oedema—Sunitinib—kidney cancer	0.000378	0.00267	CcSEcCtD
Trisalicylate-choline—Epistaxis—Paclitaxel—kidney cancer	0.000376	0.00265	CcSEcCtD
Trisalicylate-choline—Anorexia—Sorafenib—kidney cancer	0.000375	0.00265	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Vinblastine—kidney cancer	0.000375	0.00264	CcSEcCtD
Trisalicylate-choline—Injection site reaction—Doxorubicin—kidney cancer	0.000375	0.00264	CcSEcCtD
Trisalicylate-choline—Constipation—Erlotinib—kidney cancer	0.000374	0.00264	CcSEcCtD
Trisalicylate-choline—Pain—Erlotinib—kidney cancer	0.000374	0.00264	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Everolimus—kidney cancer	0.000373	0.00263	CcSEcCtD
Trisalicylate-choline—Shock—Sunitinib—kidney cancer	0.000372	0.00263	CcSEcCtD
Trisalicylate-choline—Erythema—Gemcitabine—kidney cancer	0.000372	0.00263	CcSEcCtD
Trisalicylate-choline—Asthma—Capecitabine—kidney cancer	0.000367	0.00259	CcSEcCtD
Trisalicylate-choline—Vomiting—Pazopanib—kidney cancer	0.000365	0.00257	CcSEcCtD
Trisalicylate-choline—Rash—Pazopanib—kidney cancer	0.000362	0.00255	CcSEcCtD
Trisalicylate-choline—Nausea—Temsirolimus—kidney cancer	0.000362	0.00255	CcSEcCtD
Trisalicylate-choline—Dermatitis—Pazopanib—kidney cancer	0.000361	0.00255	CcSEcCtD
Trisalicylate-choline—Anorexia—Sunitinib—kidney cancer	0.000361	0.00255	CcSEcCtD
Trisalicylate-choline—Skin exfoliation—Doxorubicin—kidney cancer	0.00036	0.00254	CcSEcCtD
Trisalicylate-choline—Headache—Pazopanib—kidney cancer	0.000359	0.00254	CcSEcCtD
Trisalicylate-choline—Oedema—Dactinomycin—kidney cancer	0.000358	0.00253	CcSEcCtD
Trisalicylate-choline—Abdominal discomfort—Capecitabine—kidney cancer	0.000352	0.00248	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Sorafenib—kidney cancer	0.000346	0.00244	CcSEcCtD
Trisalicylate-choline—Oesophagitis—Doxorubicin—kidney cancer	0.000344	0.00243	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Sorafenib—kidney cancer	0.000342	0.00241	CcSEcCtD
Trisalicylate-choline—Anorexia—Dactinomycin—kidney cancer	0.000341	0.00241	CcSEcCtD
Trisalicylate-choline—Nausea—Pazopanib—kidney cancer	0.000341	0.00241	CcSEcCtD
Trisalicylate-choline—Ecchymosis—Doxorubicin—kidney cancer	0.000341	0.0024	CcSEcCtD
Trisalicylate-choline—PTGS1—Overview of nanoparticle effects—PTGS2—kidney cancer	0.000341	0.0105	CbGpPWpGaD
Trisalicylate-choline—Erythema multiforme—Paclitaxel—kidney cancer	0.000338	0.00239	CcSEcCtD
Trisalicylate-choline—Pain—Sorafenib—kidney cancer	0.000336	0.00237	CcSEcCtD
Trisalicylate-choline—Constipation—Sorafenib—kidney cancer	0.000336	0.00237	CcSEcCtD
Trisalicylate-choline—Weight increased—Capecitabine—kidney cancer	0.000334	0.00236	CcSEcCtD
Trisalicylate-choline—Tinnitus—Paclitaxel—kidney cancer	0.000334	0.00235	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Sunitinib—kidney cancer	0.000333	0.00235	CcSEcCtD
Trisalicylate-choline—Flushing—Paclitaxel—kidney cancer	0.000332	0.00234	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Sunitinib—kidney cancer	0.000329	0.00232	CcSEcCtD
Trisalicylate-choline—PTGS2—Arachidonic acid metabolism—PTGS1—kidney cancer	0.000325	0.00998	CbGpPWpGaD
Trisalicylate-choline—Constipation—Sunitinib—kidney cancer	0.000324	0.00228	CcSEcCtD
Trisalicylate-choline—Pain—Sunitinib—kidney cancer	0.000324	0.00228	CcSEcCtD
Trisalicylate-choline—Pruritus—Everolimus—kidney cancer	0.000321	0.00226	CcSEcCtD
Trisalicylate-choline—Oedema—Vincristine—kidney cancer	0.00032	0.00226	CcSEcCtD
Trisalicylate-choline—Urticaria—Sorafenib—kidney cancer	0.000312	0.0022	CcSEcCtD
Trisalicylate-choline—Erythema—Paclitaxel—kidney cancer	0.000311	0.0022	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Dactinomycin—kidney cancer	0.000311	0.0022	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Vinblastine—kidney cancer	0.000311	0.0022	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Everolimus—kidney cancer	0.00031	0.00219	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Vincristine—kidney cancer	0.000309	0.00218	CcSEcCtD
Trisalicylate-choline—Pruritus—Erlotinib—kidney cancer	0.000309	0.00218	CcSEcCtD
Trisalicylate-choline—Epistaxis—Capecitabine—kidney cancer	0.000309	0.00218	CcSEcCtD
Trisalicylate-choline—Pain—Dactinomycin—kidney cancer	0.000306	0.00216	CcSEcCtD
Trisalicylate-choline—Anorexia—Vincristine—kidney cancer	0.000305	0.00215	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Paclitaxel—kidney cancer	0.000305	0.00215	CcSEcCtD
Trisalicylate-choline—Oedema—Gemcitabine—kidney cancer	0.000304	0.00214	CcSEcCtD
Trisalicylate-choline—Dizziness—Vinblastine—kidney cancer	0.000301	0.00212	CcSEcCtD
Trisalicylate-choline—Dizziness—Everolimus—kidney cancer	0.0003	0.00211	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Erlotinib—kidney cancer	0.000299	0.00211	CcSEcCtD
Trisalicylate-choline—Hypotension—Vincristine—kidney cancer	0.000299	0.00211	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Dactinomycin—kidney cancer	0.000295	0.00208	CcSEcCtD
Trisalicylate-choline—Hepatitis—Capecitabine—kidney cancer	0.000294	0.00207	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Gemcitabine—kidney cancer	0.000294	0.00207	CcSEcCtD
Trisalicylate-choline—Anorexia—Gemcitabine—kidney cancer	0.000289	0.00204	CcSEcCtD
Trisalicylate-choline—Vomiting—Vinblastine—kidney cancer	0.000289	0.00204	CcSEcCtD
Trisalicylate-choline—Dizziness—Erlotinib—kidney cancer	0.000289	0.00204	CcSEcCtD
Trisalicylate-choline—Vomiting—Everolimus—kidney cancer	0.000288	0.00203	CcSEcCtD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUNB—kidney cancer	0.000287	0.00879	CbGpPWpGaD
Trisalicylate-choline—Rash—Everolimus—kidney cancer	0.000286	0.00202	CcSEcCtD
Trisalicylate-choline—Dermatitis—Everolimus—kidney cancer	0.000285	0.00201	CcSEcCtD
Trisalicylate-choline—Headache—Vinblastine—kidney cancer	0.000285	0.00201	CcSEcCtD
Trisalicylate-choline—Headache—Everolimus—kidney cancer	0.000284	0.002	CcSEcCtD
Trisalicylate-choline—Hypotension—Gemcitabine—kidney cancer	0.000284	0.002	CcSEcCtD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—CD34—kidney cancer	0.000284	0.0087	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Eicosanoid Synthesis—PTGS2—kidney cancer	0.000283	0.00867	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—kidney cancer	0.00028	0.00858	CbGpPWpGaD
Trisalicylate-choline—Lethargy—Doxorubicin—kidney cancer	0.000279	0.00197	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Vincristine—kidney cancer	0.000278	0.00196	CcSEcCtD
Trisalicylate-choline—Pruritus—Sorafenib—kidney cancer	0.000278	0.00196	CcSEcCtD
Trisalicylate-choline—Vomiting—Erlotinib—kidney cancer	0.000278	0.00196	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Capecitabine—kidney cancer	0.000278	0.00196	CcSEcCtD
Trisalicylate-choline—PTGS1—Biological oxidations—ALDH1A1—kidney cancer	0.000277	0.0085	CbGpPWpGaD
Trisalicylate-choline—Rash—Erlotinib—kidney cancer	0.000276	0.00194	CcSEcCtD
Trisalicylate-choline—Dermatitis—Erlotinib—kidney cancer	0.000275	0.00194	CcSEcCtD
Trisalicylate-choline—Headache—Erlotinib—kidney cancer	0.000274	0.00193	CcSEcCtD
Trisalicylate-choline—Tinnitus—Capecitabine—kidney cancer	0.000274	0.00193	CcSEcCtD
Trisalicylate-choline—Pain—Vincristine—kidney cancer	0.000274	0.00193	CcSEcCtD
Trisalicylate-choline—Constipation—Vincristine—kidney cancer	0.000274	0.00193	CcSEcCtD
Trisalicylate-choline—Flushing—Capecitabine—kidney cancer	0.000273	0.00192	CcSEcCtD
Trisalicylate-choline—Nausea—Vinblastine—kidney cancer	0.00027	0.00191	CcSEcCtD
Trisalicylate-choline—Somnolence—Gemcitabine—kidney cancer	0.00027	0.0019	CcSEcCtD
Trisalicylate-choline—Nausea—Everolimus—kidney cancer	0.000269	0.0019	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Sorafenib—kidney cancer	0.000269	0.0019	CcSEcCtD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—EGR1—kidney cancer	0.000268	0.00822	CbGpPWpGaD
Trisalicylate-choline—Pruritus—Sunitinib—kidney cancer	0.000268	0.00189	CcSEcCtD
Trisalicylate-choline—PTGS1—Arachidonic acid metabolism—CYP1A1—kidney cancer	0.000264	0.0081	CbGpPWpGaD
Trisalicylate-choline—Decreased appetite—Gemcitabine—kidney cancer	0.000264	0.00186	CcSEcCtD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—SCARB1—kidney cancer	0.000264	0.00808	CbGpPWpGaD
Trisalicylate-choline—Dizziness—Sorafenib—kidney cancer	0.00026	0.00184	CcSEcCtD
Trisalicylate-choline—Pain—Gemcitabine—kidney cancer	0.00026	0.00183	CcSEcCtD
Trisalicylate-choline—Constipation—Gemcitabine—kidney cancer	0.00026	0.00183	CcSEcCtD
Trisalicylate-choline—Nausea—Erlotinib—kidney cancer	0.00026	0.00183	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Sunitinib—kidney cancer	0.000259	0.00183	CcSEcCtD
Trisalicylate-choline—Confusional state—Paclitaxel—kidney cancer	0.000256	0.00181	CcSEcCtD
Trisalicylate-choline—Erythema—Capecitabine—kidney cancer	0.000256	0.0018	CcSEcCtD
Trisalicylate-choline—Oedema—Paclitaxel—kidney cancer	0.000254	0.00179	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Capecitabine—kidney cancer	0.00025	0.00177	CcSEcCtD
Trisalicylate-choline—Dizziness—Sunitinib—kidney cancer	0.00025	0.00177	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Gemcitabine—kidney cancer	0.00025	0.00177	CcSEcCtD
Trisalicylate-choline—Shock—Paclitaxel—kidney cancer	0.00025	0.00176	CcSEcCtD
Trisalicylate-choline—Vomiting—Sorafenib—kidney cancer	0.00025	0.00176	CcSEcCtD
Trisalicylate-choline—Abdominal pain upper—Doxorubicin—kidney cancer	0.00025	0.00176	CcSEcCtD
Trisalicylate-choline—Rash—Sorafenib—kidney cancer	0.000248	0.00175	CcSEcCtD
Trisalicylate-choline—Dermatitis—Sorafenib—kidney cancer	0.000248	0.00175	CcSEcCtD
Trisalicylate-choline—Headache—Sorafenib—kidney cancer	0.000246	0.00174	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Paclitaxel—kidney cancer	0.000246	0.00173	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Dactinomycin—kidney cancer	0.000245	0.00173	CcSEcCtD
Trisalicylate-choline—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—kidney cancer	0.000244	0.0075	CbGpPWpGaD
Trisalicylate-choline—Anorexia—Paclitaxel—kidney cancer	0.000242	0.00171	CcSEcCtD
Trisalicylate-choline—Vomiting—Sunitinib—kidney cancer	0.000241	0.0017	CcSEcCtD
Trisalicylate-choline—Rash—Sunitinib—kidney cancer	0.000239	0.00168	CcSEcCtD
Trisalicylate-choline—Dermatitis—Sunitinib—kidney cancer	0.000238	0.00168	CcSEcCtD
Trisalicylate-choline—Hypotension—Paclitaxel—kidney cancer	0.000238	0.00168	CcSEcCtD
Trisalicylate-choline—Headache—Sunitinib—kidney cancer	0.000237	0.00167	CcSEcCtD
Trisalicylate-choline—Asthma—Doxorubicin—kidney cancer	0.000236	0.00167	CcSEcCtD
Trisalicylate-choline—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—kidney cancer	0.000236	0.00725	CbGpPWpGaD
Trisalicylate-choline—Nausea—Sorafenib—kidney cancer	0.000234	0.00165	CcSEcCtD
Trisalicylate-choline—Vomiting—Dactinomycin—kidney cancer	0.000228	0.00161	CcSEcCtD
Trisalicylate-choline—Somnolence—Paclitaxel—kidney cancer	0.000226	0.00159	CcSEcCtD
Trisalicylate-choline—Rash—Dactinomycin—kidney cancer	0.000226	0.00159	CcSEcCtD
Trisalicylate-choline—Nausea—Sunitinib—kidney cancer	0.000225	0.00159	CcSEcCtD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—CYP1A1—kidney cancer	0.000224	0.00688	CbGpPWpGaD
Trisalicylate-choline—Dyspepsia—Paclitaxel—kidney cancer	0.000224	0.00158	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Paclitaxel—kidney cancer	0.000221	0.00156	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Vincristine—kidney cancer	0.000219	0.00155	CcSEcCtD
Trisalicylate-choline—Constipation—Paclitaxel—kidney cancer	0.000217	0.00153	CcSEcCtD
Trisalicylate-choline—Pain—Paclitaxel—kidney cancer	0.000217	0.00153	CcSEcCtD
Trisalicylate-choline—Weight increased—Doxorubicin—kidney cancer	0.000215	0.00152	CcSEcCtD
Trisalicylate-choline—Pruritus—Gemcitabine—kidney cancer	0.000215	0.00152	CcSEcCtD
Trisalicylate-choline—PTGS2—S1P1 pathway—VEGFA—kidney cancer	0.000213	0.00653	CbGpPWpGaD
Trisalicylate-choline—Nausea—Dactinomycin—kidney cancer	0.000213	0.0015	CcSEcCtD
Trisalicylate-choline—Dizziness—Vincristine—kidney cancer	0.000212	0.00149	CcSEcCtD
Trisalicylate-choline—Drowsiness—Doxorubicin—kidney cancer	0.000211	0.00149	CcSEcCtD
Trisalicylate-choline—Confusional state—Capecitabine—kidney cancer	0.00021	0.00148	CcSEcCtD
Trisalicylate-choline—PTGS2—Arachidonic acid metabolism—CYP1A1—kidney cancer	0.00021	0.00643	CbGpPWpGaD
Trisalicylate-choline—Feeling abnormal—Paclitaxel—kidney cancer	0.000209	0.00148	CcSEcCtD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—SCARB1—kidney cancer	0.000209	0.00642	CbGpPWpGaD
Trisalicylate-choline—Oedema—Capecitabine—kidney cancer	0.000209	0.00147	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Gemcitabine—kidney cancer	0.000208	0.00147	CcSEcCtD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—PTGS1—kidney cancer	0.000207	0.00635	CbGpPWpGaD
Trisalicylate-choline—Shock—Capecitabine—kidney cancer	0.000205	0.00145	CcSEcCtD
Trisalicylate-choline—Vomiting—Vincristine—kidney cancer	0.000203	0.00144	CcSEcCtD
Trisalicylate-choline—Sweating—Doxorubicin—kidney cancer	0.000202	0.00143	CcSEcCtD
Trisalicylate-choline—Urticaria—Paclitaxel—kidney cancer	0.000202	0.00143	CcSEcCtD
Trisalicylate-choline—Rash—Vincristine—kidney cancer	0.000202	0.00142	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Capecitabine—kidney cancer	0.000202	0.00142	CcSEcCtD
Trisalicylate-choline—Dermatitis—Vincristine—kidney cancer	0.000202	0.00142	CcSEcCtD
Trisalicylate-choline—PTGS2—S1P1 pathway—MAPK3—kidney cancer	0.000202	0.00618	CbGpPWpGaD
Trisalicylate-choline—Headache—Vincristine—kidney cancer	0.000201	0.00141	CcSEcCtD
Trisalicylate-choline—Epistaxis—Doxorubicin—kidney cancer	0.000199	0.0014	CcSEcCtD
Trisalicylate-choline—Anorexia—Capecitabine—kidney cancer	0.000199	0.0014	CcSEcCtD
Trisalicylate-choline—Hypotension—Capecitabine—kidney cancer	0.000195	0.00138	CcSEcCtD
Trisalicylate-choline—Vomiting—Gemcitabine—kidney cancer	0.000193	0.00136	CcSEcCtD
Trisalicylate-choline—PTGS2—S1P1 pathway—MAPK1—kidney cancer	0.000192	0.00588	CbGpPWpGaD
Trisalicylate-choline—Rash—Gemcitabine—kidney cancer	0.000191	0.00135	CcSEcCtD
Trisalicylate-choline—Dermatitis—Gemcitabine—kidney cancer	0.000191	0.00135	CcSEcCtD
Trisalicylate-choline—Headache—Gemcitabine—kidney cancer	0.00019	0.00134	CcSEcCtD
Trisalicylate-choline—Nausea—Vincristine—kidney cancer	0.00019	0.00134	CcSEcCtD
Trisalicylate-choline—Hepatitis—Doxorubicin—kidney cancer	0.000189	0.00134	CcSEcCtD
Trisalicylate-choline—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A1—kidney cancer	0.000185	0.00568	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.000185	0.00568	CbGpPWpGaD
Trisalicylate-choline—Dyspepsia—Capecitabine—kidney cancer	0.000184	0.0013	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Capecitabine—kidney cancer	0.000181	0.00128	CcSEcCtD
Trisalicylate-choline—Nausea—Gemcitabine—kidney cancer	0.00018	0.00127	CcSEcCtD
Trisalicylate-choline—Pruritus—Paclitaxel—kidney cancer	0.00018	0.00127	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Doxorubicin—kidney cancer	0.000179	0.00126	CcSEcCtD
Trisalicylate-choline—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—kidney cancer	0.000179	0.00548	CbGpPWpGaD
Trisalicylate-choline—Constipation—Capecitabine—kidney cancer	0.000178	0.00126	CcSEcCtD
Trisalicylate-choline—Pain—Capecitabine—kidney cancer	0.000178	0.00126	CcSEcCtD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—SOD2—kidney cancer	0.000178	0.00546	CbGpPWpGaD
Trisalicylate-choline—Tinnitus—Doxorubicin—kidney cancer	0.000176	0.00125	CcSEcCtD
Trisalicylate-choline—Flushing—Doxorubicin—kidney cancer	0.000176	0.00124	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Paclitaxel—kidney cancer	0.000174	0.00123	CcSEcCtD
Trisalicylate-choline—PTGS2—Calcium signaling in the CD4+ TCR pathway—JUN—kidney cancer	0.000174	0.00533	CbGpPWpGaD
Trisalicylate-choline—Feeling abnormal—Capecitabine—kidney cancer	0.000172	0.00121	CcSEcCtD
Trisalicylate-choline—Dizziness—Paclitaxel—kidney cancer	0.000168	0.00119	CcSEcCtD
Trisalicylate-choline—Urticaria—Capecitabine—kidney cancer	0.000166	0.00117	CcSEcCtD
Trisalicylate-choline—Erythema—Doxorubicin—kidney cancer	0.000165	0.00116	CcSEcCtD
Trisalicylate-choline—PTGS1—Biological oxidations—GSTT1—kidney cancer	0.000163	0.00499	CbGpPWpGaD
Trisalicylate-choline—Vomiting—Paclitaxel—kidney cancer	0.000162	0.00114	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Doxorubicin—kidney cancer	0.000161	0.00114	CcSEcCtD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—ANXA1—kidney cancer	0.000161	0.00493	CbGpPWpGaD
Trisalicylate-choline—Rash—Paclitaxel—kidney cancer	0.00016	0.00113	CcSEcCtD
Trisalicylate-choline—Dermatitis—Paclitaxel—kidney cancer	0.00016	0.00113	CcSEcCtD
Trisalicylate-choline—Headache—Paclitaxel—kidney cancer	0.000159	0.00112	CcSEcCtD
Trisalicylate-choline—PTGS1—Arachidonic acid metabolism—PTGS2—kidney cancer	0.000157	0.00482	CbGpPWpGaD
Trisalicylate-choline—Nausea—Paclitaxel—kidney cancer	0.000151	0.00107	CcSEcCtD
Trisalicylate-choline—PTGS2—Signaling mediated by p38-alpha and p38-beta—JUN—kidney cancer	0.00015	0.00459	CbGpPWpGaD
Trisalicylate-choline—Pruritus—Capecitabine—kidney cancer	0.000148	0.00104	CcSEcCtD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—GSTM1—kidney cancer	0.000146	0.00448	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—APAF1—kidney cancer	0.000144	0.00442	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—JUND—kidney cancer	0.000144	0.00442	CbGpPWpGaD
Trisalicylate-choline—Diarrhoea—Capecitabine—kidney cancer	0.000143	0.00101	CcSEcCtD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—SOD2—kidney cancer	0.000141	0.00433	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.000138	0.00423	CbGpPWpGaD
Trisalicylate-choline—Dizziness—Capecitabine—kidney cancer	0.000138	0.000974	CcSEcCtD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—RAF1—kidney cancer	0.000138	0.00423	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—RELA—kidney cancer	0.000137	0.00421	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—kidney cancer	0.000137	0.00419	CbGpPWpGaD
Trisalicylate-choline—Confusional state—Doxorubicin—kidney cancer	0.000136	0.000957	CcSEcCtD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—EGR1—kidney cancer	0.000135	0.00414	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.000135	0.00413	CbGpPWpGaD
Trisalicylate-choline—Oedema—Doxorubicin—kidney cancer	0.000134	0.000949	CcSEcCtD
Trisalicylate-choline—Vomiting—Capecitabine—kidney cancer	0.000133	0.000936	CcSEcCtD
Trisalicylate-choline—Shock—Doxorubicin—kidney cancer	0.000132	0.000934	CcSEcCtD
Trisalicylate-choline—Rash—Capecitabine—kidney cancer	0.000132	0.000928	CcSEcCtD
Trisalicylate-choline—Dermatitis—Capecitabine—kidney cancer	0.000131	0.000927	CcSEcCtD
Trisalicylate-choline—Headache—Capecitabine—kidney cancer	0.000131	0.000922	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Doxorubicin—kidney cancer	0.00013	0.000917	CcSEcCtD
Trisalicylate-choline—Anorexia—Doxorubicin—kidney cancer	0.000128	0.000905	CcSEcCtD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—kidney cancer	0.000126	0.00387	CbGpPWpGaD
Trisalicylate-choline—Hypotension—Doxorubicin—kidney cancer	0.000126	0.000887	CcSEcCtD
Trisalicylate-choline—Nausea—Capecitabine—kidney cancer	0.000124	0.000874	CcSEcCtD
Trisalicylate-choline—Somnolence—Doxorubicin—kidney cancer	0.00012	0.000844	CcSEcCtD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—ACHE—kidney cancer	0.000119	0.00365	CbGpPWpGaD
Trisalicylate-choline—Dyspepsia—Doxorubicin—kidney cancer	0.000118	0.000835	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Doxorubicin—kidney cancer	0.000117	0.000825	CcSEcCtD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—kidney cancer	0.000116	0.00355	CbGpPWpGaD
Trisalicylate-choline—Constipation—Doxorubicin—kidney cancer	0.000115	0.000811	CcSEcCtD
Trisalicylate-choline—Pain—Doxorubicin—kidney cancer	0.000115	0.000811	CcSEcCtD
Trisalicylate-choline—PTGS1—Biological oxidations—GSTP1—kidney cancer	0.000113	0.00346	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—kidney cancer	0.000112	0.00345	CbGpPWpGaD
Trisalicylate-choline—Feeling abnormal—Doxorubicin—kidney cancer	0.000111	0.000782	CcSEcCtD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—ANXA1—kidney cancer	0.000109	0.00335	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—KIT—kidney cancer	0.000108	0.00333	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.000107	0.00328	CbGpPWpGaD
Trisalicylate-choline—Urticaria—Doxorubicin—kidney cancer	0.000107	0.000754	CcSEcCtD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—kidney cancer	0.000105	0.00322	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Biological oxidations—GSTM1—kidney cancer	0.000104	0.00318	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—RELA—kidney cancer	0.000103	0.00316	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—PTGS2—kidney cancer	0.0001	0.00307	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—kidney cancer	9.88e-05	0.00303	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Biological oxidations—CYP1A1—kidney cancer	9.83e-05	0.00302	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	9.81e-05	0.00301	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	9.81e-05	0.00301	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—MYC—kidney cancer	9.66e-05	0.00296	CbGpPWpGaD
Trisalicylate-choline—Pruritus—Doxorubicin—kidney cancer	9.51e-05	0.000671	CcSEcCtD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—kidney cancer	9.45e-05	0.0029	CbGpPWpGaD
Trisalicylate-choline—Diarrhoea—Doxorubicin—kidney cancer	9.2e-05	0.000649	CcSEcCtD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	9.17e-05	0.00281	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—KRAS—kidney cancer	8.93e-05	0.00274	CbGpPWpGaD
Trisalicylate-choline—Dizziness—Doxorubicin—kidney cancer	8.89e-05	0.000628	CcSEcCtD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—CDKN2A—kidney cancer	8.81e-05	0.0027	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ACY1—kidney cancer	8.65e-05	0.00265	CbGpPWpGaD
Trisalicylate-choline—Vomiting—Doxorubicin—kidney cancer	8.55e-05	0.000603	CcSEcCtD
Trisalicylate-choline—Rash—Doxorubicin—kidney cancer	8.48e-05	0.000598	CcSEcCtD
Trisalicylate-choline—Dermatitis—Doxorubicin—kidney cancer	8.47e-05	0.000598	CcSEcCtD
Trisalicylate-choline—Headache—Doxorubicin—kidney cancer	8.42e-05	0.000594	CcSEcCtD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—CD4—kidney cancer	8.3e-05	0.00254	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—RELA—kidney cancer	8.17e-05	0.0025	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	8.05e-05	0.00247	CbGpPWpGaD
Trisalicylate-choline—Nausea—Doxorubicin—kidney cancer	7.99e-05	0.000564	CcSEcCtD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	7.98e-05	0.00245	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—CDKN1B—kidney cancer	7.8e-05	0.00239	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—kidney cancer	7.8e-05	0.00239	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—CCND1—kidney cancer	7.44e-05	0.00228	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	7.38e-05	0.00226	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PDHB—kidney cancer	7.35e-05	0.00226	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Biological oxidations—POMC—kidney cancer	7.33e-05	0.00225	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CCBL1—kidney cancer	6.91e-05	0.00212	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ACY1—kidney cancer	6.87e-05	0.00211	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CCBL1—kidney cancer	6.55e-05	0.00201	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	6.25e-05	0.00192	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PPAT—kidney cancer	6e-05	0.00184	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GLIPR1—kidney cancer	6e-05	0.00184	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—MYC—kidney cancer	5.97e-05	0.00183	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—CDKN1B—kidney cancer	5.94e-05	0.00182	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—AMER1—kidney cancer	5.93e-05	0.00182	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	5.92e-05	0.00182	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	5.86e-05	0.0018	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PDHB—kidney cancer	5.84e-05	0.00179	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—IL2—kidney cancer	5.82e-05	0.00178	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—CCND1—kidney cancer	5.67e-05	0.00174	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	5.62e-05	0.00172	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—APRT—kidney cancer	5.57e-05	0.00171	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—FH—kidney cancer	5.57e-05	0.00171	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—KRAS—kidney cancer	5.52e-05	0.00169	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CCBL1—kidney cancer	5.49e-05	0.00168	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	5.45e-05	0.00167	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GPC3—kidney cancer	5.24e-05	0.00161	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CA2—kidney cancer	5.1e-05	0.00156	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ALAD—kidney cancer	4.97e-05	0.00152	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—GPC3—kidney cancer	4.97e-05	0.00152	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	4.96e-05	0.00152	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ST3GAL2—kidney cancer	4.85e-05	0.00149	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GLIPR1—kidney cancer	4.76e-05	0.00146	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PPAT—kidney cancer	4.76e-05	0.00146	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ALDH1A1—kidney cancer	4.74e-05	0.00145	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	4.7e-05	0.00144	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—MAPK3—kidney cancer	4.68e-05	0.00143	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	4.65e-05	0.00143	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—ST3GAL2—kidney cancer	4.6e-05	0.00141	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—MYC—kidney cancer	4.55e-05	0.00139	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PGK1—kidney cancer	4.54e-05	0.00139	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—SLC5A3—kidney cancer	4.54e-05	0.00139	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—LDHB—kidney cancer	4.46e-05	0.00137	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—MAPK1—kidney cancer	4.45e-05	0.00136	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—FH—kidney cancer	4.42e-05	0.00136	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—APRT—kidney cancer	4.42e-05	0.00136	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	4.41e-05	0.00135	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	4.37e-05	0.00134	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	4.32e-05	0.00133	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—SLC5A3—kidney cancer	4.31e-05	0.00132	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PGK1—kidney cancer	4.31e-05	0.00132	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—LDHB—kidney cancer	4.22e-05	0.0013	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—SFRP2—kidney cancer	4.22e-05	0.0013	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GPC3—kidney cancer	4.16e-05	0.00128	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CA2—kidney cancer	4.05e-05	0.00124	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	4.04e-05	0.00124	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ALAD—kidney cancer	3.94e-05	0.00121	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—TCEB2—kidney cancer	3.94e-05	0.00121	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—TCEB1—kidney cancer	3.94e-05	0.00121	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CA9—kidney cancer	3.86e-05	0.00118	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	3.86e-05	0.00118	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ST3GAL2—kidney cancer	3.85e-05	0.00118	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	3.85e-05	0.00118	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	3.82e-05	0.00117	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3.78e-05	0.00116	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ALDH1A1—kidney cancer	3.76e-05	0.00115	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—TP53—kidney cancer	3.74e-05	0.00115	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	3.72e-05	0.00114	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PGK1—kidney cancer	3.61e-05	0.00111	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SLC5A3—kidney cancer	3.61e-05	0.00111	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—LDHB—kidney cancer	3.54e-05	0.00108	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	3.36e-05	0.00103	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CRABP1—kidney cancer	3.29e-05	0.00101	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—RPL14—kidney cancer	3.2e-05	0.000982	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	3.18e-05	0.000976	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	3.09e-05	0.000949	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CA9—kidney cancer	3.07e-05	0.000941	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ITPR2—kidney cancer	3.05e-05	0.000937	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	3.03e-05	0.000928	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3e-05	0.000919	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—ITPR2—kidney cancer	2.89e-05	0.000888	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	2.86e-05	0.000877	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.82e-05	0.000863	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GSTT1—kidney cancer	2.78e-05	0.000854	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ACHE—kidney cancer	2.78e-05	0.000854	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—SCARB1—kidney cancer	2.64e-05	0.000809	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	2.63e-05	0.000806	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CRABP1—kidney cancer	2.61e-05	0.0008	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PSMD7—kidney cancer	2.56e-05	0.000785	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	2.54e-05	0.000779	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—BCHE—kidney cancer	2.43e-05	0.000744	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PSMD7—kidney cancer	2.43e-05	0.000744	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ITPR2—kidney cancer	2.42e-05	0.000744	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—SLC5A5—kidney cancer	2.4e-05	0.000735	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—SLC2A1—kidney cancer	2.31e-05	0.00071	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.25e-05	0.000689	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.23e-05	0.000685	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ACHE—kidney cancer	2.21e-05	0.000678	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GSTT1—kidney cancer	2.21e-05	0.000678	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—SLC2A1—kidney cancer	2.19e-05	0.000673	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—JUNB—kidney cancer	2.18e-05	0.000668	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SCARB1—kidney cancer	2.09e-05	0.000642	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PTGS1—kidney cancer	2.07e-05	0.000635	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PSMD7—kidney cancer	2.03e-05	0.000623	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.96e-05	0.000601	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GSTP1—kidney cancer	1.93e-05	0.000592	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—BCHE—kidney cancer	1.93e-05	0.000591	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SLC5A5—kidney cancer	1.9e-05	0.000583	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SLC2A1—kidney cancer	1.84e-05	0.000564	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ABCB1—kidney cancer	1.83e-05	0.00056	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GSTM1—kidney cancer	1.77e-05	0.000544	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CDKN2B—kidney cancer	1.77e-05	0.000544	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CYP1A1—kidney cancer	1.68e-05	0.000516	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.55e-05	0.000477	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GSTP1—kidney cancer	1.53e-05	0.00047	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ABCB1—kidney cancer	1.45e-05	0.000445	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—HIF1A—kidney cancer	1.42e-05	0.000435	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—TSC2—kidney cancer	1.41e-05	0.000434	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GSTM1—kidney cancer	1.41e-05	0.000432	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.38e-05	0.000424	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYP1A1—kidney cancer	1.33e-05	0.000409	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—POMC—kidney cancer	1.25e-05	0.000385	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—APC—kidney cancer	1.25e-05	0.000383	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—KIT—kidney cancer	1.25e-05	0.000383	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—BRAF—kidney cancer	1.17e-05	0.00036	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.1e-05	0.000336	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PTGS2—kidney cancer	1e-05	0.000307	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—POMC—kidney cancer	9.95e-06	0.000305	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—RAF1—kidney cancer	9.8e-06	0.000301	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—ERBB2—kidney cancer	9.69e-06	0.000297	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—MTOR—kidney cancer	9.57e-06	0.000293	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CD4—kidney cancer	9.55e-06	0.000293	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CDKN1B—kidney cancer	8.98e-06	0.000275	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PTEN—kidney cancer	8.72e-06	0.000267	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CTNNB1—kidney cancer	8.48e-06	0.00026	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PTEN—kidney cancer	8.27e-06	0.000254	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—MAPK3—kidney cancer	7.06e-06	0.000217	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PTEN—kidney cancer	6.92e-06	0.000212	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—MYC—kidney cancer	6.87e-06	0.000211	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—MAPK1—kidney cancer	6.72e-06	0.000206	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—KRAS—kidney cancer	6.35e-06	0.000195	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PIK3CA—kidney cancer	6.15e-06	0.000189	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PIK3CA—kidney cancer	5.83e-06	0.000179	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PIK3CA—kidney cancer	4.88e-06	0.00015	CbGpPWpGaD
